Literature DB >> 22062200

Left ventricular assist device driveline infections.

Daniel Pereda1, John V Conte.   

Abstract

This article reviews some important aspects of driveline infection in patients under left ventricular assist device (LVAD) support, including epidemiology, causes, diagnosis, and treatment options, both medical and surgical. Focus is placed on prevention along every aspect of the process of LVAD therapy, as the authors believe this is the most efficient measure to fight driveline infections. Once driveline infection is present, early recognition and adequate treatment, including surgical measures, play a central role management, and are key to achieving the goals of LVAD support.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22062200     DOI: 10.1016/j.ccl.2011.08.004

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  11 in total

1.  Diagnosis of infection in patients with left ventricular assist device: PET or SPECT?

Authors:  Damien Legallois; Alain Manrique
Journal:  J Nucl Cardiol       Date:  2018-06-12       Impact factor: 5.952

2.  Left ventricle assist devices and driveline's infection incidence: a single-centre experience.

Authors:  Jonida Bejko; Francesca Toto; Dario Gregori; Gino Gerosa; Tomaso Bottio
Journal:  J Artif Organs       Date:  2017-10-07       Impact factor: 1.731

Review 3.  Continuous-flow left ventricular assist device systems infections: current outcomes and management strategies.

Authors:  Nana Aburjania; Christine M Hay; Muhammad R Sohail
Journal:  Ann Cardiothorac Surg       Date:  2021-03

4.  The Effect of Judge Selection on Standard Setting Using the Mastery Angoff Method during Development of a Ventricular Assist Device Self-Care Curriculum.

Authors:  Jeffrey H Barsuk; Rebecca S Harap; Elaine R Cohen; Kenzie A Cameron; Kathleen L Grady; Jane E Wilcox; Kerry B Shanklin; Diane B Wayne
Journal:  Clin Simul Nurs       Date:  2018-11-27       Impact factor: 2.391

Review 5.  Left ventricular assist device driveline infections: recent advances and future goals.

Authors:  Anne-Marie Leuck
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

6.  Short-term Retention of Patient and Caregiver Ventricular Assist Device Self-care Skills after Simulation-based Mastery Learning.

Authors:  Jeffrey H Barsuk; Elaine R Cohen; Kenzie A Cameron; Kathleen L Grady; Jane E Wilcox; Kerry B Shanklin; Rebecca S Harap; Gretchen P Nonog; Diane B Wayne
Journal:  Clin Simul Nurs       Date:  2021-02-15       Impact factor: 2.391

7.  The Role of Computed Tomography in Predicting Left Ventricular Assist Device Infectious Complications.

Authors:  Carrie K Gomez; Scott R Schiffman; Susan K Hobbs
Journal:  J Clin Imaging Sci       Date:  2016-10-21

Review 8.  Driveline Infection in Ventricular Assist Devices and Its Implication in the Present Era of Destination Therapy.

Authors:  Gabriel A Hernandez; Jonatan D Nunez Breton; Sandra V Chaparro
Journal:  Open J Cardiovasc Surg       Date:  2017-06-22

9.  2019 EACTS Expert Consensus on long-term mechanical circulatory support.

Authors:  Evgenij V Potapov; Christiaan Antonides; Maria G Crespo-Leiro; Alain Combes; Gloria Färber; Margaret M Hannan; Marian Kukucka; Nicolaas de Jonge; Antonio Loforte; Lars H Lund; Paul Mohacsi; Michiel Morshuis; Ivan Netuka; Mustafa Özbaran; Federico Pappalardo; Anna Mara Scandroglio; Martin Schweiger; Steven Tsui; Daniel Zimpfer; Finn Gustafsson
Journal:  Eur J Cardiothorac Surg       Date:  2019-08-01       Impact factor: 4.191

10.  Effect of Ventricular Assist Device Self-care Simulation-Based Mastery Learning on Driveline Exit Site Infections: A Pilot Study.

Authors:  Jane E Wilcox; Rebecca S Harap; Valentina Stosor; Elaine R Cohen; Kathleen L Grady; Kenzie A Cameron; Denise M Scholtens; Diane B Wayne; Kerry B Shanklin; Gretchen P Nonog; Lauren E Schulze; Alison M Jirak; Grace C Magliola; Jeffrey H Barsuk
Journal:  J Cardiovasc Nurs       Date:  2022 May-Jun 01       Impact factor: 2.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.